Ginsenoside Rg3 inhibits tumor necrosis factor-alpha-induced expression of cell adhesion molecules in human endothelial cells.
Hien
Tran Thi
TT
BK21 Project Team, College of Pharmacy, Chosun University, Gwangju, South Korea.
Kim
Nak Doo
ND
Kim
Hyung Sik
HS
Kang
Keon Wook
KW
D015153:Blotting, Western; D015815:Cell Adhesion Molecules / Q000096:biosynthesis*; D002460:Cell Line; D016207:Cytokines / Q000096:biosynthesis; D004305:Dose-Response Relationship, Drug; D042783:Endothelial Cells / Q000187:drug effects / Q000378:metabolism*; D004797:Enzyme-Linked Immunosorbent Assay; D036145:Ginsenosides / Q000494:pharmacology*; D006801:Humans; D007202:Indicators and Reagents; D016328:NF-kappa B / Q000096:biosynthesis / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D018808:Transcription Factor AP-1 / Q000037:antagonists & inhibitors / Q000235:genetics; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000494:pharmacology
D015815:Cell Adhesion Molecules; D016207:Cytokines; D036145:Ginsenosides; D007202:Indicators and Reagents; D016328:NF-kappa B; D018808:Transcription Factor AP-1; D014409:Tumor Necrosis Factor-alpha; C097367:ginsenoside Rg3